Adrenocorticotropic Hormone (ACTH)-Induced Dyskinesias in Infantile Spasms: A Video Case Report

Ana C S Crippa1, Dafne L Bayer1, Luciana de Paula Souza2

  • 1Neurology Pediatric Unit, Universidade Federal do Paraná, Curitiba, PR, Brazil.

Insights

Adrenocorticotropic hormone (ACTH) therapy for infantile spasms can cause dyskinetic movements, which are not seizures. These movements resolve after treatment completion, highlighting a potential misdiagnosis in infantile spasms management.

Area of Science:

  • Neurology
  • Pediatrics
  • Endocrinology

Background:

  • Infantile spasms is a severe epilepsy syndrome in infants.
  • Adrenocorticotropic hormone (ACTH) is a primary treatment, but has side effects.
  • Adverse effects of ACTH in infantile spasms are not well-documented.

Observation:

  • Four infants treated with ACTH developed involuntary, asymmetric movements.
  • These movements resembled dyskinesia, not epileptic seizures.
  • Electroencephalography (EEG) showed no epileptic activity during these episodes.

Findings:

  • ACTH therapy can induce dyskinetic movements in infants with infantile spasms.
  • These movements are distinct from infantile spasms seizures.
  • Involuntary movements ceased post-ACTH treatment.

Implications:

  • Recognizing ACTH-induced dyskinesia is crucial to avoid misdiagnosis.
  • This distinction prevents inappropriate escalation of epilepsy treatment.
  • Further research into ACTH's neurological side effects is warranted.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
636
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
421
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
707
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
506